246 related articles for article (PubMed ID: 10424641)
1. The utility of Medicare claims data for measuring cancer stage.
Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
[TBL] [Abstract][Full Text] [Related]
2. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
[TBL] [Abstract][Full Text] [Related]
3. The sensitivity of Medicare claims data for case ascertainment of six common cancers.
Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
Med Care; 1999 May; 37(5):436-44. PubMed ID: 10335746
[TBL] [Abstract][Full Text] [Related]
4. Use of SEER-Medicare data for measuring cancer surgery.
Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL
Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167
[TBL] [Abstract][Full Text] [Related]
5. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
7. Measuring complications of cancer treatment using the SEER-Medicare data.
Potosky AL; Warren JL; Riedel ER; Klabunde CN; Earle CC; Begg CB
Med Care; 2002 Aug; 40(8 Suppl):IV-62-8. PubMed ID: 12187170
[TBL] [Abstract][Full Text] [Related]
8. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
[TBL] [Abstract][Full Text] [Related]
9. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
[TBL] [Abstract][Full Text] [Related]
10. Studying radiation therapy using SEER-Medicare-linked data.
Virnig BA; Warren JL; Cooper GS; Klabunde CN; Schussler N; Freeman J
Med Care; 2002 Aug; 40(8 Suppl):IV-49-54. PubMed ID: 12187168
[TBL] [Abstract][Full Text] [Related]
11. Potential for cancer related health services research using a linked Medicare-tumor registry database.
Potosky AL; Riley GF; Lubitz JD; Mentnech RM; Kessler LG
Med Care; 1993 Aug; 31(8):732-48. PubMed ID: 8336512
[TBL] [Abstract][Full Text] [Related]
12. Information gained from linking SEER Cancer Registry Data to state-level hospital discharge abstracts. Surveillance, Epidemiology, and End Results.
Brooks JM; Chrischilles E; Scott S; Ritho J; Chen-Hardee S
Med Care; 2000 Nov; 38(11):1131-40. PubMed ID: 11078053
[TBL] [Abstract][Full Text] [Related]
13. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
McCarthy EP; Ngo LH; Chirikos TN; Roetzheim RG; Li D; Drews RE; Iezzoni LI
Health Serv Res; 2007 Apr; 42(2):611-28. PubMed ID: 17362209
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
15. Mammography use, breast cancer stage at diagnosis, and survival among older women.
McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
[TBL] [Abstract][Full Text] [Related]
16. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
[TBL] [Abstract][Full Text] [Related]
17. Comparison of SEER Treatment Data With Medicare Claims.
Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
[TBL] [Abstract][Full Text] [Related]
18. Validation of electronic data on chemotherapy and hormone therapy use in HMOs.
Ritzwoller DP; Carroll N; Delate T; O'Keeffe-Rossetti M; Fishman PA; Loggers ET; Aiello Bowles EJ; Elston-Lafata J; Hornbrook MC
Med Care; 2013 Oct; 51(10):e67-73. PubMed ID: 22531648
[TBL] [Abstract][Full Text] [Related]
19. Utility of the SEER-Medicare data to identify chemotherapy use.
Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
[TBL] [Abstract][Full Text] [Related]
20. The sensitivity of Medicare data for identifying incident cases of invasive melanoma (United States).
Barzilai DA; Koroukian SM; Neuhauser D; Cooper KD; Rimm AA; Cooper GS
Cancer Causes Control; 2004 Mar; 15(2):179-84. PubMed ID: 15017130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
